Compounds > substance p
Page last updated: 2024-08-23

substance p and Cranial Nerve V Diseases

substance p has been researched along with Cranial Nerve V Diseases in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (28.57)29.6817
2010's4 (57.14)24.3611
2020's1 (14.29)2.80

Authors

AuthorsStudies
Issar, T; Krishnan, AV; Kwai, N; Markoulli, M; Pisarcikova, J; Poynten, AM; Tummanapalli, SS; Willcox, MDP1
Duong, CL; Karras, J; Kim, J; Lum, E; Markoulli, M; Tolentino, JB; You, J1
Demartini, C; Deseure, K; Francesconi, O; Greco, R; Nativi, C; Tassorelli, C; Zanaboni, AM1
Chikama, T; Morishige, N; Nishida, T; Sonoda, KH; Yamada, N; Yanai, R1
Arantes, RME; Costa, GMF; da Silva Camargos, ER; de Almeida-Leite, CM; de Oliveira, AP; Martinelli, PM1
Kawahara, M; Nakamura, M; Nakata, K; Nishida, T1
Brown, SM; Khanani, AM; Reid, TW; Stetson, CL1

Reviews

1 review(s) available for substance p and Cranial Nerve V Diseases

ArticleYear
Potential New Modes of Treatment of Neurotrophic Keratopathy.
    Cornea, 2015, Volume: 34 Suppl 11

    Topics: Clinical Trials as Topic; Drug Synergism; Epithelium, Corneal; Humans; Insulin-Like Growth Factor I; Keratitis; Neurotransmitter Agents; Ophthalmic Solutions; Substance P; Trigeminal Nerve Diseases

2015

Other Studies

6 other study(ies) available for substance p and Cranial Nerve V Diseases

ArticleYear
A Comparative Study on the Diagnostic Utility of Corneal Confocal Microscopy and Tear Neuromediator Levels in Diabetic Peripheral Neuropathy.
    Current eye research, 2020, Volume: 45, Issue:8

    Topics: Adult; Area Under Curve; Calcitonin Gene-Related Peptide; Cornea; Corneal Diseases; Cross-Sectional Studies; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Enzyme-Linked Immunosorbent Assay; Female; Humans; Male; Microscopy, Confocal; Middle Aged; Prospective Studies; ROC Curve; Substance P; Tears; Trigeminal Nerve Diseases

2020
Corneal Nerve Morphology and Tear Film Substance P in Diabetes.
    Optometry and vision science : official publication of the American Academy of Optometry, 2017, Volume: 94, Issue:7

    Topics: Case-Control Studies; Cornea; Corneal Diseases; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Eye Proteins; Female; Humans; Male; Microscopy, Confocal; Middle Aged; Nerve Fibers; Prospective Studies; Substance P; Tears; Trigeminal Nerve; Trigeminal Nerve Diseases

2017
Antagonism of Transient Receptor Potential Ankyrin Type-1 Channels as a Potential Target for the Treatment of Trigeminal Neuropathic Pain: Study in an Animal Model.
    International journal of molecular sciences, 2018, Oct-25, Volume: 19, Issue:11

    Topics: Animals; Calcitonin Gene-Related Peptide; Disease Models, Animal; Hyperalgesia; Immunohistochemistry; Male; Pain; Rats; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction; Substance P; Trigeminal Nerve Diseases; TRPA1 Cation Channel; TRPV Cation Channels

2018
Demyelination/remyelination and expression of interleukin-1β, substance P, nerve growth factor, and glial-derived neurotrophic factor during trigeminal neuropathic pain in rats.
    Neuroscience letters, 2016, Jan-26, Volume: 612

    Topics: Animals; Glial Cell Line-Derived Neurotrophic Factor; Interleukin-1beta; Male; Nerve Fibers, Myelinated; Nerve Growth Factor; Rats, Wistar; Substance P; Trigeminal Ganglion; Trigeminal Nerve; Trigeminal Nerve Diseases

2016
Restoration of corneal epithelial barrier function and wound healing by substance P and IGF-1 in rats with capsaicin-induced neurotrophic keratopathy.
    Investigative ophthalmology & visual science, 2003, Volume: 44, Issue:7

    Topics: Administration, Topical; Animals; Biological Transport; Capsaicin; Cornea; Corneal Diseases; Disease Models, Animal; Drug Therapy, Combination; Epithelium, Corneal; Female; Fluorescein; Fluorophotometry; Insulin-Like Growth Factor I; Male; Ophthalmic Solutions; Pregnancy; Rats; Rats, Wistar; Substance P; Tears; Trigeminal Nerve Diseases; Wound Healing

2003
Vesicular eruption in a child with trigeminal nerve palsy during topical therapy with substance p and insulinlike growth factor I for neurotrophic keratitis.
    Archives of ophthalmology (Chicago, Ill. : 1960), 2004, Volume: 122, Issue:11

    Topics: Accidents, Traffic; Administration, Topical; Child, Preschool; Cornea; Drug Eruptions; Drug Therapy, Combination; Female; Humans; Insulin-Like Growth Factor I; Keratitis; Ophthalmic Solutions; Skin Diseases, Vesiculobullous; Substance P; Trigeminal Nerve Diseases

2004